[First report in Peru on direct-acting antiviral therapy for chronic hepatitis C in HIV-positive patients].

Objective: To present the clinical experience with direct-acting antivirals (DAAs) for chronic hepatitis C in HIV-positive patients.

Materials And Methods: Longitudinal and prospective case series of HIV-positive patients treated with DAAs for chronic hepatitis C between May 2019 and April 2020 at the Infectious Diseases Service of Hospital G. Almenara, EsSalud.